Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Iginio Colaiori

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Minerva Cardiology and Angiology|May 12, 2025
Serum uric acid and prognosis in coronary bifurcation lesions treated with drug-eluting stentsAttilio Lauretti, Iginio Colaiori, Francesco Versaci
Cardiovascular Diagnosis and Therapy|December 1, 2018
Antiplatelet therapy in valvular and structural heart disease interventionsAnnunziata Nusca, Edoardo Bressi, Iginio Colaiori, et al.
Journal of the American College of Cardiology|March 16, 2019
Hyperemic Pressure-Flow Relationship in a HumanStephane Fournier, Iginio Colaiori, Giuseppe Di Gioia, et al.
Circulation. Cardiovascular Interventions|May 16, 2019
Long-Term Patency of Coronary Artery Bypass Grafts After Fractional Flow Reserve-Guided ImplantationStephane Fournier, Gabor G Toth, Iginio Colaiori, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|August 14, 2016
Heart Rate reduction by IVabradine for improvement of ENDothELial function in patients with coronary artery disease: the RIVENDEL studyFabio Mangiacapra, Iginio Colaiori, Elisabetta Ricottini, et al.
Circulation|September 14, 2016
Clopidogrel Versus Ticagrelor for Antiplatelet Maintenance in Diabetic Patients Treated With Percutaneous Coronary Intervention: Results of the CLOTILDIA Study (Clopidogrel High Dose Versus Ticagrelor for Antiplatelet Maintenance in Diabetic Patients)Fabio Mangiacapra, Elena Panaioli, Iginio Colaiori, et al.
The American Journal of Cardiology|August 13, 2016
Relation of Neutrophil to Lymphocyte Ratio With Periprocedural Myocardial Damage in Patients Undergoing Elective Percutaneous Coronary InterventionEdoardo Bressi, Fabio Mangiacapra, Elisabetta Ricottini, et al.
Journal of Cardiovascular Pharmacology|August 8, 2024
Clinical Performance and Persistence on Dual Pathway Inhibition with Rivaroxaban and Aspirin in Real-World SettingVincenzo Russo, Dario Fabiani, Egidio Imbalzano, et al.
International Journal of Cardiology|November 18, 2016
Should pre-operative left atrial volume receive more consideration in patients with degenerative mitral valve disease undergoing mitral valve surgery?Giuseppe Di Gioia, Simona Mega, Antonio Nenna, et al.
Pacing and Clinical Electrophysiology : PACE|August 23, 2018
Interrupted versus uninterrupted novel oral anticoagulant peri-implantation of cardiac device: A single-center randomized prospective pilot trialDanilo Ricciardi, Antonio Creta, Iginio Colaiori, et al.
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Minerva Cardiology and Angiology|May 12, 2025
Serum uric acid and prognosis in coronary bifurcation lesions treated with drug-eluting stentsAttilio Lauretti, Iginio Colaiori, Francesco Versaci
Cardiovascular Diagnosis and Therapy|December 1, 2018
Antiplatelet therapy in valvular and structural heart disease interventionsAnnunziata Nusca, Edoardo Bressi, Iginio Colaiori, et al.
Journal of the American College of Cardiology|March 16, 2019
Hyperemic Pressure-Flow Relationship in a HumanStephane Fournier, Iginio Colaiori, Giuseppe Di Gioia, et al.
Circulation. Cardiovascular Interventions|May 16, 2019
Long-Term Patency of Coronary Artery Bypass Grafts After Fractional Flow Reserve-Guided ImplantationStephane Fournier, Gabor G Toth, Iginio Colaiori, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|August 14, 2016
Heart Rate reduction by IVabradine for improvement of ENDothELial function in patients with coronary artery disease: the RIVENDEL studyFabio Mangiacapra, Iginio Colaiori, Elisabetta Ricottini, et al.
Circulation|September 14, 2016
Clopidogrel Versus Ticagrelor for Antiplatelet Maintenance in Diabetic Patients Treated With Percutaneous Coronary Intervention: Results of the CLOTILDIA Study (Clopidogrel High Dose Versus Ticagrelor for Antiplatelet Maintenance in Diabetic Patients)Fabio Mangiacapra, Elena Panaioli, Iginio Colaiori, et al.
The American Journal of Cardiology|August 13, 2016
Relation of Neutrophil to Lymphocyte Ratio With Periprocedural Myocardial Damage in Patients Undergoing Elective Percutaneous Coronary InterventionEdoardo Bressi, Fabio Mangiacapra, Elisabetta Ricottini, et al.
Journal of Cardiovascular Pharmacology|August 8, 2024
Clinical Performance and Persistence on Dual Pathway Inhibition with Rivaroxaban and Aspirin in Real-World SettingVincenzo Russo, Dario Fabiani, Egidio Imbalzano, et al.
International Journal of Cardiology|November 18, 2016
Should pre-operative left atrial volume receive more consideration in patients with degenerative mitral valve disease undergoing mitral valve surgery?Giuseppe Di Gioia, Simona Mega, Antonio Nenna, et al.
Pacing and Clinical Electrophysiology : PACE|August 23, 2018
Interrupted versus uninterrupted novel oral anticoagulant peri-implantation of cardiac device: A single-center randomized prospective pilot trialDanilo Ricciardi, Antonio Creta, Iginio Colaiori, et al.
Pageof 7